- Home
- BBDO vs GEHC Comparison
BBDO vs GEHC Comparison
Compare BBDO & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBDO | GEHC |
|---|---|---|
| Founded | 1943 | 1892 |
| Country | Brazil | United States |
| Employees | 82095 | N/A |
| Industry | Major Banks | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.4B | 35.8B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | BBDO | GEHC |
|---|---|---|
| Price | $3.38 | $70.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 12 |
| Target Price | N/A | ★ $90.83 |
| AVG Volume (30 Days) | 78.0K | ★ 3.2M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.67% | 0.20% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $70.95 | $7.06 |
| Revenue Next Year | $8.23 | $4.50 |
| P/E Ratio | ★ $9.20 | $15.46 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $1.81 | $57.65 |
| 52 Week High | $3.77 | $89.77 |
Technical Indicators
Market Signals| Indicator | BBDO | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.15 | 40.59 |
| Support Level | $3.36 | $69.72 |
| Resistance Level | $3.76 | $74.67 |
| Average True Range (ATR) | 0.10 | 1.77 |
| MACD | 0.03 | 0.29 |
| Stochastic Oscillator | 94.68 | 35.05 |
Price Performance
Historical ComparisonAbout BBDO Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation, a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).